FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wolfgang Sperr

Research Profile

Anatomy

Disorders

Chemicals & Drugs

Physiology

Histamine Release

Living Beings

Pollen

Co-author Network

Publications

TOP 3
Jason Gotlib; Karin Hartmann; Olivier Hermine; Hans-Peter Horny; Hanneke Kluin-Nelemans; Dean D Metcalfe; Alberto Orfao; Animesh Pardanani; Andreas Reiter; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Ayalew Tefferi; Cem Akin; Michel AROCK; Knut Brockow; Daniel J Deangelo; Luis Escribano; Tracy George; Srdan Verstovsek; Peter Valent
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.
Peter Valent; Friedrich Wimazal; Stefan Wöhrl; Brigitte Zahel; Wolfgang R Sperr; Elisabeth Aberer; Christine Beham-Schmid; Christina Fellinger; Wolfgang Fuchs; Karoline V Gleixner; Rosemarie Greul; Emir Hadzijusufovic; Gregor Hoermann; Hubert Pehamberger
Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM).
Harald Herrmann; Hans-Peter Horny; Leonhard Müllauer; Junwei Shi; Wolfgang R Sperr; Christopher R Vakoc; Katharina Blatt; James E Bradner; Sabine Cerny-Reiterer; Karoline V Gleixner; Johannes Zuber; Peter Valent
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wolfgang Sperr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jason Gotlib; Karin Hartmann; Olivier Hermine; Hans-Peter Horny; Hanneke Kluin-Nelemans; Dean D Metcalfe; Alberto Orfao; Animesh Pardanani; Andreas Reiter; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Ayalew Tefferi; Cem Akin; Michel AROCK; Knut Brockow; Daniel J Deangelo; Luis Escribano; Tracy George; Srdan Verstovsek; Peter Valent
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.
Blood 2013;121(13):2393-401.
2013: Peter Valent; Friedrich Wimazal; Stefan Wöhrl; Brigitte Zahel; Wolfgang R Sperr; Elisabeth Aberer; Christine Beham-Schmid; Christina Fellinger; Wolfgang Fuchs; Karoline V Gleixner; Rosemarie Greul; Emir Hadzijusufovic; Gregor Hoermann; Hubert Pehamberger
Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM).
American journal of blood research 2013;3(2):174-80.
2012: Harald Herrmann; Hans-Peter Horny; Leonhard Müllauer; Junwei Shi; Wolfgang R Sperr; Christopher R Vakoc; Katharina Blatt; James E Bradner; Sabine Cerny-Reiterer; Karoline V Gleixner; Johannes Zuber; Peter Valent
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
Oncotarget 2012;3(12):1588-99.
2012: Peter Valent; Jaap J VanDoormaal; Judit Várkonyi; Selim Yavuz; Michel AROCK; Patrizia Bonadonna; Knut Brockow; Sigurd Broesby-Olsen; Luis Escribano; Karoline V Gleixner; Clive Grattan; Emir Hadzijusufovic; Hans Hägglund; Olivier Hermine; Hans-Peter Horny; Hanneke C Kluin-Nelemans; Marcus Maurer; Boguslaw Nedoszytko; Marek Niedoszytko; Gunnar Nilsson; Alberto Orfao; Hanneke N G Oude-Elberink; Deepti Radia; Andreas Reiter; Frank Siebenhaar; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Karin Hartmann
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives.
Wiener klinische Wochenschrift 2012;124(23-24):807-14.
2012: Heimo Lagler; Theresia Popow-Kraupp; Michael Ramharter; Monika Redlberger-Fritz; Wolfgang R Sperr; Selma Tobudic; Christoph C Zielinski; Katarzyna Elandt; Ulrich Jäger; Heinz Burgmann
Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation.
Vaccine 2012;30(48):6864-70.
2012: Peter Valent; Peter Vandenberghe; Peter F Weller; Michel AROCK; Joseph H Butterfield; Jason Gotlib; Torsten Haferlach; Andrzej Hellmann; Hans-Peter Horny; Amy D Klion; Kristin M Leiferman; Georgia Metzgeroth; Andreas Reiter; Florence Roufosse; Hans-Uwe Simon; Karl Sotlar; Wolfgang R Sperr; Gerald J Gleich
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.
The Journal of allergy and clinical immunology 2012;130(3):607-612.e9.
2012: Wolfgang R Sperr; Peter Valent
Diagnosis, progression patterns and prognostication in mastocytosis.
Expert review of hematology 2012;5(3):261-74.
2012: Isabella Fried; Karin Lind; Werner Linkesch; Monika M Pichler; Franz Quehenberger; Heinz Sill; Wolfgang R Sperr; Christine Beham-Schmid; Claudia Bodner; Albert Wölfler
Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia.
Haematologica 2012;97(2):246-50.
2012: Harald Herrmann; Eva Jäger; Gerlinde Mitterbauer-Hohendanner; Werner Rabitsch; Ilse Schwarzinger; Edgar Selzer; Wolfgang R Sperr; Berthold Streubel; Katharina Blatt; Sabine Cerny-Reiterer; Karoline V Gleixner; Susanne Herndlhofer; Peter Valent
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin.
Haematologica 2012;97(2):219-26.
2012: H Herrmann; M Kneidinger; Hiroshi Maeda; Matthias Mayerhofer; B Peter; Winfried F Pickl; Puchit Samorapoompichit; Wolfgang R Sperr; G Y Bharate; K Blatt; S Cerny-Reiterer; Karoline V Gleixner; Michael Willmann; G Hörmann; T Rülicke; Peter Valent
The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cells.
Current cancer drug targets 2012;12(1):51-63.
2012: Friedrich Wimazal; Philipp Geissler; Patrik Shnawa; Wolfgang R Sperr; Peter Valent
Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience.
International archives of allergy and immunology 2012;157(4):399-405.
2012: Peter Valent; Rudolf Valenta; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Cem Akin; Michel AROCK; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Hans-Peter Horny; Philip Lieberman; Dean D Metcalfe
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.
International archives of allergy and immunology 2012;157(3):215-25.
2011: Alexandra Boehm; Anja Bojic; Klaus Laczika; Gottfried J Locker; Werner Rabitsch; Oliver Robak; Viktoria Siersch; Thomas Staudinger; Peter Valent; Nina Worel; Wolfgang R Sperr
Successful allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia during respiratory failure and invasive mechanical ventilation.
Wiener klinische Wochenschrift 2011;123(11-12):354-8.
2011: Alexandra Böhm; Harald Herrmann; Gerlinde Mitterbauer-Hohendanner; Alexander W Hauswirth; Werner Rabitsch; Margit Mitterbauer; Wolfgang R Sperr; Peter Kalhs; Ulrich Jäger; Peter Valent
Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet 'pre-leukemic' stem cells?
Leukemia & lymphoma 2011;52(5):842-8.
2011: Judith Loeffler-Ragg; U Germing; Wolfgang R Sperr; H Herrmann; Heinz Zwierzina; Peter Valent; Hanno Ulmer; Reinhard Stauder
Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromes.
Critical reviews in oncology/hematology 2011;78(2):150-61.
2011: Peter Schellongowski; Viktoria Siersch; Wolfgang R Sperr; Roman Ullrich; Anja Bojic; Valentin Fuhrmann; Klaus-Bernhard Gattringer; Alexander Hermann; Maria Hermann; Hubert Hetz; Cornelia Hieber; Klaus Laczika; Gottfried J Locker; Heidrun Losert; Werner Rabitsch; Oliver Robak; Thomas Staudinger
A surge of flu-associated adult respiratory distress syndrome in an Austrian tertiary care hospital during the 2009/2010 Influenza A H1N1v pandemic.
Wiener klinische Wochenschrift 2011;123(7-8):209-14.
2011: Peter Schellongowski; Thomas Staudinger; Michael Kundi; Klaus Laczika; Gottfried J Locker; Anja Bojic; Oliver Robak; Valentin Fuhrmann; Ulrich Jäger; Peter Valent; Wolfgang R Sperr
Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience.
Haematologica 2011;96(2):231-7.
2011: Peter Valent; Eva Jäger; Gerlinde Mitterbauer-Hohendanner; Leonhard Müllauer; Ilse Schwarzinger; Wolfgang R Sperr; Renate Thalhammer; Friedrich Wimazal
Idiopathic bone marrow dysplasia of unknown significance (IDUS): definition, pathogenesis, follow up, and prognosis.
American journal of cancer research 2011;1(4):531-41.
2011: Volker Wacheck; Michael Lahn; Gemma Dickinson; Wolfgang Füreder; Renata Meyer; Susanne Herndlhofer; Thorsten Füreder; Georg Dorfner; Sada Pillay; Valérie André; Timothy P Burkholder; Jacqueline K Akunda; Leann Flye-Blakemore; Dirk Van Bockstaele; Richard F Schlenk; Wolfgang R Sperr; Peter Valent
Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics.
Cancer management and research 2011;3():157-75.
2011: Alexandra Boehm; Barbara Walcherberger; Wolfgang R Sperr; Stefan Wöhrer; Karin Dieckmann; Agathe Rosenmayr; Elisabeth Pernicka; Gottfried Fischer; Nina Worel; Gerlinde Mitterbauer; Ilse Schwarzinger; Margit Mitterbauer; Oskar A Haas; Klaus Lechner; W Hinterberger; Peter Valent; Hildegard T Greinix; Werner Rabitsch; Peter Kalhs
Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(1):133-40.
2010: Peter Valent; Wolfgang R Sperr; Cem Akin
How I treat patients with advanced systemic mastocytosis.
Blood 2010;116(26):5812-7.
2010: Peter Valent; Attilio Orazi; Guntram Büsche; Annette Schmitt-Gräff; Tracy I George; Karl Sotlar; Berthold Streubel; Christine Beham-Schmid; Sabine Cerny-Reiterer; Otto Krieger; Arjan van de Loosdrecht; Wolfgang Kern; Kiyoyuki Ogata; Friedrich Wimazal; Judit Várkonyi; Wolfgang R Sperr; Martin Werner; Hans Kreipe; Hans-Peter Horny
Standards and impact of hematopathology in myelodysplastic syndromes (MDS).
Oncotarget 2010;1(7):483-96.
2010: Peter Valent; Sabine Cerny-Reiterer; Harald Herrmann; Irina Mirkina; Tracy I George; Karl Sotlar; Wolfgang R Sperr; Hans-Peter Horny
Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells.
Best practice & research. Clinical haematology 2010;23(3):369-78.
2010: Alexandra Böhm; Karoline Sonneck; Karoline V Gleixner; Karina Schuch; Winfried F Pickl; Katharina Blatt; Barbara Peter; Harald Herrmann; Gerit-Holger Schernthaner; Hubert Pehamberger; Werner Rabitsch; Wolfgang R Sperr; Peter Valent
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.
Experimental hematology 2010;38(9):744-55.
2010: Peter Valent; Michel AROCK; Cem Akin; Wolfgang R Sperr; Andreas Reiter; Karl Sotlar; Karin Hartmann; Tracy I George; Knut Brockow; Hanneke C Kluin-Nelemans; Jason Gotlib; Dean D Metcalfe; Hans-Peter Horny
The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD).
Blood 2010;116(5):850-1.
2010: Robert Fritsche-Polanz; Marika Fritz; Andrea Huber; Karl Sotlar; Wolfgang R Sperr; Christine Mannhalter; Manuela Födinger; Peter Valent
High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.
Molecular oncology 2010;4(4):335-46.
2010: Peter Valent; Cem Akin; Wolfgang R Sperr; Hans-Peter Horny; Dean D Metcalfe
Refinements in response criteria in systemic mastocytosis: reply to a proposal.
European journal of haematology 2010;85(1):88-9; author reply 90.
2010: Friedrich Wimazal; Ulrich Germing; Michael Kundi; Thomas Noesslinger; Sabine Blum; Philipp Geissler; Christian Baumgartner; Michael Pfeilstoecker; Peter Valent; Wolfgang R Sperr
Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes.
Cancer 2010;116(10):2372-81.
2010: Daniel Heintel; Cathrin Skrabs; Alexander W Hauswirth; Karin Eigenberger; Christine Einberger; Markus Raderer; Wolfgang R Sperr; Paul Knoebl; Leonhard Müllauer; Martin Uffmann; Karin Dieckmann; Alexander Gaiger; Ulrich Jäger
Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age.
Annals of hematology 2010;89(2):163-9.
2010: Thomas Nösslinger; Heinz Tüchler; Ulrich Germing; Wolfgang R Sperr; O Krieger; Detlef Haase; Michael Lübbert; R Stauder; A Giagounidis; P Valent; Michael Pfeilstöcker
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(1):120-5.
2010: Wolfgang R Sperr; Friedrich Wimazal; Michael Kundi; Christian Baumgartner; Thomas Nösslinger; A Makrai; Reinhard Stauder; Otto Krieger; Michael Pfeilstöcker; Peter Valent
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(1):114-9.
2009: Alexandra Boehm; Matthias Mayerhofer; Susanne Herndlhofer; Paul Knoebl; Christian Sillaber; Wolfgang R Sperr; Ulrich Jaeger; Peter Valent
Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML.
European journal of internal medicine 2009;20(8):775-8.
2009: Peter Valent; Wolfgang R Sperr; Manuela Födinger; Michael Kundi
Comorbidity, iron overload and HFE variants: a new prognostic complex in MDS?
European journal of clinical investigation 2009;39(12):1112-3.
2009: Fernando P G Silva; Inês Almeida; Bruno Morolli; Geeske Brouwer-Mandema; Hans Wessels; Rolf Vossen; Harry Vrieling; Erik W A Marijt; Peter J M Valk; Hanneke C Kluin-Nelemans; Wolfgang R Sperr; Wolf-Dieter Ludwig; Micheline Giphart-Gassler
Genome wide molecular analysis of minimally differentiated acute myeloid leukemia.
Haematologica 2009;94(11):1546-54.
2009: Wolfgang R Sperr; A El-Samahi; Michael Kundi; M Girschikofsky; Stefan Winkler; D Lutz; Georg Endler; Helmut Rumpold; Hermine Agis; Christian Sillaber; Ulrich Jäger; Peter Valent
Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology.
European journal of clinical investigation 2009;39(10):914-23.
2009: Peter Valent; Wolf-Karsten Hofmann; Guntram Büsche; Karl Sotlar; Hans-Peter Horny; Detlef Haase; Torsten Haferlach; Wolfgang Kern; Peter Bettelheim; Christian Baumgartner; Wolfgang R Sperr; Thomas Nösslinger; Friedrich Wimazal; Aristoteles A Giagounidis; Michael Lübbert; Otto Krieger; Hans-Jochem Kolb; Reinhard Stauder; Michael Pfeilstöcker; Norbert Gattermann; Christa Fonatsch; Carlo Aul; Ulrich Germing
Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes.
Annals of hematology 2009;88(7):607-11.
2009: Alexandra Böhm; Karl J Aichberger; Matthias Mayerhofer; H Herrmann; Stefan Florian; Maria-Theresa Krauth; Sophia Derdak; Puchit Samorapoompichit; Karoline Sonneck; Anja Vales; Karoline V Gleixner; Winfried F Pickl; Wolfgang R Sperr; Peter Valent
Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
European journal of clinical investigation 2009;39(5):395-405.
2009: Friedrich Wimazal; Thomas Nösslinger; Christoph Baumgartner; Wolfgang R Sperr; Michael Pfeilstöcker; Peter Valent
Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes.
European journal of clinical investigation 2009;39(5):406-11.
2008: A Boehm; Wolfgang R Sperr; Gerda C Leitner; Nina Worel; Leopold Oehler; E Jaeger; Margit Mitterbauer; Oskar A Haas; Peter Valent; Peter Kalhs; Werner Rabitsch
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.
European journal of clinical investigation 2008;38(12):945-52.
2008: Karl J Aichberger; Wolfgang R Sperr; Karoline V Gleixner; A Kretschmer; Peter Valent
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis.
European journal of clinical investigation 2008;38(11):869-73.
2008: Syed Khizer Hasan; Ashley N Mays; Tiziana Ottone; Antonio Ledda; Giorgio La Nasa; Chiara Cattaneo; Erika Borlenghi; Lorella Melillo; Enrico Montefusco; José Cervera; Christopher Stephen; Gnanam Satchi; Anne Lennard; Marta Libura; Jo Ann W Byl; Neil Osheroff; Sergio Amadori; Carolyn A Felix; Maria Teresa Voso; Wolfgang R Sperr; Jordi Esteve; Miguel A Sanz; David Grimwade; Francesco Lo Coco
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.
Blood 2008;112(8):3383-90.
2008: Alexander W Hauswirth; Luis Escribano; A Prados; R Nuñez; I Mirkina; M Kneidinger; Stefan Florian; Karoline Sonneck; Anja Vales; Gerit-Holger Schernthaner; L Sanchez-Muñoz; Wolfgang R Sperr; H-J Bühring; Alberto Orfao; Peter Valent
CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking.
International journal of immunopathology and pharmacology 2008;21(4):797-806.
2008: Reinhard Stauder; Thomas Nösslinger; Michael Pfeilstöcker; Wolfgang R Sperr; Friedrich Wimazal; Otto Krieger; Peter Valent
Impact of age and comorbidity in myelodysplastic syndromes.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):927-34.
2008: Alexander W Hauswirth; Manuela Födinger; Marika Fritz; Leonhard Müllauer; Ingrid Simonitsch-Klupp; Berthold Streubel; Andreas Chott; Wolfgang R Sperr; Ulrich Jäger; Peter Valent
Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
Human pathology 2008;39(6):917-24.
2008: Friedrich Wimazal; Christian Baumgartner; Karoline Sonneck; Christian Zauner; P Geissler; S Schur; Puchit Samorapoompichit; Leonhard Müllauer; Manuela Födinger; Hermine Agis; Wolfgang R Sperr; Peter Valent
Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression.
European journal of clinical investigation 2008;38(6):447-55.
2008: Friedrich Wimazal; Wolfgang R Sperr; M Kundi; Anja Vales; Christa Fonatsch; Renate Thalhammer-Scherrer; Ilse Schwarzinger; Peter Valent
Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):970-6.
2008: Matthias Mayerhofer; Karoline V Gleixner; Andrea Hoelbl; Stefan Florian; Gregor Hoermann; Karl J Aichberger; Martin Bilban; Harald Esterbauer; Maria-Theresa Krauth; Wolfgang R Sperr; Jack B Longley; Robert Kralovics; Richard Moriggl; Jacques Zappulla; Roland S Liblau; Ilse Schwarzinger; Veronika Sexl; Christian Sillaber; Peter Valent
Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(8):5466-76.
2008: Katja Haas; Michael Kundi; Wolfgang R Sperr; Harald Esterbauer; Wolf-Dieter Ludwig; Richard Ratei; Elisabeth Koller; Helga Gruener; Cristina Sauerland; Christa Fonatsch; Peter Valent; Rotraud Wieser
Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.
Genes, chromosomes & cancer 2008;47(4):288-98.
2008: Peter Valent; Otto Krieger; Reinhard Stauder; Friedrich Wimazal; Thomas Nösslinger; Wolfgang R Sperr; H Sill; P Bettelheim; Michael Pfeilstöcker
Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform.
European journal of clinical investigation 2008;38(3):143-9.
2008: Reinhard Stauder; Friedrich Wimazal; Thomas Nösslinger; Otto Krieger; Wolfgang R Sperr; Heinz Sill; Michael Pfeilstöcker; Peter Valent
[Individualized management and therapy of myelodysplastic syndromes].
Wiener klinische Wochenschrift 2008;120(17-18):523-37.
2008: Christian Sillaber; Matthias Mayerhofer; Alexandra Böhm; Anja Vales; Alexander Gruze; Karl J Aichberger; Harald Esterbauer; Michael Pfeilstöcker; Wolfgang R Sperr; Winfried F Pickl; Oskar A Haas; Peter Valent
Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia.
European journal of clinical investigation 2008;38(1):43-52.
2007: Hermine Agis; Wolfgang R Sperr; S Herndlhofer; Hans Semper; Hendrati Pirc-Danoewinata; Oskar A Haas; Christine Mannhalter; Harald Esterbauer; Klaus Geissler; Christian Sillaber; Ulrich Jäger; Peter Valent
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1834-41.
2007: Friedrich Wimazal; Christa Fonatsch; Renate Thalhammer; Ilse Schwarzinger; Leonhard Müllauer; Wolfgang R Sperr; John M Bennett; Peter Valent
Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.
Leukemia research 2007;31(11):1461-8.
2007: Anja Vales; Rudin Kondo; Karl J Aichberger; Matthias Mayerhofer; Birgit Kainz; Wolfgang R Sperr; Christian Sillaber; Ulrich Jäger; Peter Valent
Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2.
Leukemia & lymphoma 2007;48(10):1997-2007.
2007: Karl J Aichberger; S Herndlhofer; Hermine Agis; Wolfgang R Sperr; Harald Esterbauer; Werner Rabitsch; Paul Knoebl; Oskar A Haas; Renate Thalhammer; Ilse Schwarzinger; Christian Sillaber; Ulrich Jäger; Peter Valent
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.
European journal of clinical investigation 2007;37(10):808-13.
2007: Andrea Zatkova; Christa Fonatsch; Wolfgang R Sperr; Peter Valent
A patient with de novo AML M1 and t(16;21) with karyotype evolution.
Leukemia research 2007;31(9):1319-21.
2007: Susanne Vrtala; Margarete Focke; Jolanta Kopec; Petra Verdino; Arnulf Hartl; Wolfgang R Sperr; Alexander A Fedorov; Tanja Ball; Steven C Almo; Peter Valent; Josef Thalhamer; Walter Keller; Rudolf Valenta
Genetic engineering of the major timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicity.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1730-9.
2007: Alexandra Böhm; Manuela Födinger; Friedrich Wimazal; Oskar A Haas; Matthias Mayerhofer; Wolfgang R Sperr; Harald Esterbauer; Peter Valent
Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.
The Journal of allergy and clinical immunology 2007;120(1):192-9.
2007: Peter Valent; Cem Akin; Luis Escribano; Manuela Födinger; K Hartmann; Knut Brockow; Mariana Castells; Wolfgang R Sperr; Hanneke C Kluin-Nelemans; Neveen Agnes Therese Hamdy; O Lortholary; Jamie Robyn; Jasper J van Doormaal; Karl Sotlar; Alexander W Hauswirth; Michel AROCK; O Hermine; A Hellmann; M Triggiani; M Niedoszytko; Lawrence B Schwartz; Alberto Orfao; Hans-Peter Horny; Dean D Metcalfe
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
European journal of clinical investigation 2007;37(6):435-53.
2007: Peter Valent; Hans-Peter Horny; John M Bennett; Christa Fonatsch; Ulrich Germing; Peter Greenberg; Torsten Haferlach; Detlef Haase; Hans-Jochen Kolb; Otto Krieger; Michael R Loken; Arjan van de Loosdrecht; Kiyoyuki Ogata; Alberto Orfao; Michael Pfeilstöcker; Björn Rüter; Wolfgang R Sperr; Reinhard Stauder; Denise A Wells
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.
Leukemia research 2007;31(6):727-36.
2007: Ines Swoboda; Agnes Bugajska-Schretter; Birgit Linhart; Petra Verdino; Walter Keller; Ulrike Schulmeister; Wolfgang R Sperr; Peter Valent; Gabriel Peltre; Santiago Quirce; Nikolaos Douladiris; Nikolaos Papadopoulos; Rudolf Valenta; Susanne Spitzauer
A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(10):6290-6.
2007: Alexander W Hauswirth; Karoline Sonneck; Stefan Florian; Maria-Theresa Krauth; A Bohm; Wolfgang R Sperr; Rudolf Valenta; Gerit-Holger Schernthaner; Dieter Printz; Gerhard Fritsch; H J Buhring; Peter Valent
Interleukin-3 promotes the expression of E-NPP3/CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergy.
International journal of immunopathology and pharmacology 2007;20(2):267-78.
2007: Wolfgang R Sperr; Klaus Lechner; Ingrid Pabinger
Rituximab for the treatment of acquired antibodies to factor VIII.
Haematologica 2007;92(1):66-71.
2007: Alexander W Hauswirth; Stefan Florian; Dieter Printz; Karl Sotlar; Maria-Theresa Krauth; Gerhard Fritsch; Gerit-Holger Schernthaner; Volker Wacheck; Edgar Selzer; Wolfgang R Sperr; Peter Valent
Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells.
European journal of clinical investigation 2007;37(1):73-82.
2007: Karoline Sonneck; Stefan Florian; Leonhard Müllauer; Friedrich Wimazal; Manuela Födinger; Wolfgang R Sperr; Peter Valent
Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.
International archives of allergy and immunology 2007;142(2):158-64.
2006: Axel Schulenburg; Herbert Ulrich-Pur; Dietmar Thurnher; Boban M Erovic; Stefan Florian; Wolfgang R Sperr; Peter Kalhs; Brigitte Marian; Fritz Wrba; Christoph C Zielinski; Peter Valent
Neoplastic stem cells: a novel therapeutic target in clinical oncology.
Cancer 2006;107(10):2512-20.
2006: Stefan Florian; Harald Esterbauer; Thomas Binder; Leonhard Müllauer; Oskar A Haas; Wolfgang R Sperr; Christian Sillaber; Peter Valent
Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.
Leukemia research 2006;30(9):1201-5.
2006: Karoline Sonneck; Stefan Florian; Alexandra Böhm; Maria-Theresa Krauth; Rudin Kondo; Alexander W Hauswirth; Karoline V Gleixner; Karl J Aichberger; Sophia Derdak; Winfried F Pickl; Wolfgang R Sperr; Lawrence B Schwartz; Peter Valent
Evaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemia.
Leukemia & lymphoma 2006;47(5):897-906.
2006: Maria-Theresa Krauth; Yasamin Majlesi; Karoline Sonneck; Puchit Samorapoompichit; Minoo Ghannadan; Alexander W Hauswirth; Mehrdad Baghestanian; Gerit-Holger Schernthaner; Christof Worda; Martin R Müller; Wolfgang R Sperr; Peter Valent
Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells.
Allergy 2006;61(3):281-8.
2006: Friedrich Wimazal; Maria-Theresa Krauth; Anja Vales; Alexandra Böhm; Hermine Agis; Karoline Sonneck; Karl J Aichberger; Matthias Mayerhofer; Ingrid Simonitsch-Klupp; Leonhard Müllauer; Wolfgang R Sperr; Peter Valent
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Leukemia & lymphoma 2006;47(3):451-60.
2006: Puchit Samorapoompichit; Gerit-Holger Schernthaner; Christof Worda; Friedrich Wimazal; Maria-Theresa Krauth; Wolfgang R Sperr; Peter Valent
Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
Histopathology 2006;48(3):247-57.
2006: Maria-Theresa Krauth; Stefan Florian; Alexandra Böhm; Karoline Sonneck; Hermine Agis; Puchit Samorapoompichit; Alexander W Hauswirth; Wolfgang R Sperr; Peter Valent
Immunological characterization and antibacterial function of persisting granulocytes in leukemic patients receiving pulse cytosine arabinoside-consolidation chemotherapy on days 1, 3, and 5.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(3):1759-68.
2006: Stefan Florian; Karoline Sonneck; Alexander W Hauswirth; Maria-Theresa Krauth; Gerit-Holger Schernthaner; Wolfgang R Sperr; Peter Valent
Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.
Leukemia & lymphoma 2006;47(2):207-22.
2006: Wolfgang Füreder; Maria-Theresa Krauth; Wolfgang R Sperr; Karoline Sonneck; Ingrid Simonitsch-Klupp; Leonhard Müllauer; Michael Willmann; Hans-Peter Horny; Peter Valent
Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemia.
The American journal of pathology 2006;168(1):123-30.
2006: Alexander W Hauswirth; Stefan Florian; Gerit-Holger Schernthaner; Maria-Theresa Krauth; Karoline Sonneck; Wolfgang R Sperr; Peter Valent
Expression of cell surface antigens on mast cells: mast cell phenotyping.
Methods in molecular biology (Clifton, N.J.) 2006;315():77-90.
2005: Wolfgang R Sperr; Johannes Drach; Alexander W Hauswirth; Jutta Ackermann; Margit Mitterbauer; Gerlinde Mitterbauer; Manuela Foedinger; Christa Fonatsch; Ingrid Simonitsch-Klupp; Peter Kalhs; Peter Valent
Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 1):6787-92.
2005: Gerit-Holger Schernthaner; Alexander W Hauswirth; Mehrdad Baghestanian; Hermine Agis; Minoo Ghannadan; Christof Worda; Maria-Theresa Krauth; Dieter Printz; Gerhard Fritsch; Wolfgang R Sperr; Peter Valent
Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors.
Allergy 2005;60(10):1248-55.
2005: Wolfgang R Sperr; Margit Mitterbauer; Gerlinde Mitterbauer; Michael Kundi; Ulrich Jäger; Klaus Lechner; Peter Valent
Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapse.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6536-43.
2005: Wolfgang R Sperr; Stefan Florian; Alexander W Hauswirth; Peter Valent
CD 33 as a target of therapy in acute myeloid leukemia: current status and future perspectives.
Leukemia & lymphoma 2005;46(8):1115-20.
2005: Karl J Aichberger; Irene Mittermann; Renate Reininger; Susanne Seiberler; Ines Swoboda; Susanne Spitzauer; Tamara Kopp; Georg Stingl; Wolfgang R Sperr; Peter Valent; Andreas Repa; Barbara Bohle; Dietrich Kraft; Rudolf Valenta
Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):1286-94.
2005: Karoline Sonneck; Christine Mannhalter; Maria-Theresa Krauth; Wolfgang R Sperr; Ilse Schwarzinger; Christa Fonatsch; Oskar A Haas; Klaus Geissler; Peter Valent
An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phase.
European journal of haematology 2005;75(1):73-7.
2005: Karin Nebral; Margit König; Helmut H Schmidt; Dieter Lutz; Wolfgang R Sperr; Krzysztof Kalwak; Stefan Brugger; Michael Dworzak; Oskar A Haas; Sabine Strehl
Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
Haematologica 2005;90(6):746-52.
2005: Alexandra Böhm; Maria Piribauer; Friedrich Wimazal; Klaus Geissler; Heinz Gisslinger; Paul Knoebl; Ulrich Jäger; Christa Fonatsch; Paul A Kyrle; Peter Valent; Klaus Lechner; Wolfgang R Sperr
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience.
Leukemia research 2005;29(6):609-15.
2005: Matthias Mayerhofer; Karl J Aichberger; Stefan Florian; Maria-Theresa Krauth; Alexander W Hauswirth; Sophia Derdak; Wolfgang R Sperr; Harald Esterbauer; Oswald Wagner; Christine Marosi; Winfried F Pickl; Michael W N Deininger; Ellen Weisberg; Brian J Druker; James D Griffin; Christian Sillaber; Peter Valent
Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(8):960-2.
2005: Stefan Florian; Minoo Ghannadan; Matthias Mayerhofer; Karl J Aichberger; Alexander W Hauswirth; Gerit-Holger Schernthaner; Dieter Printz; Gerhard Fritsch; Alexandra Böhm; Karoline Sonneck; Maria-Theresa Krauth; Martin R Müller; Christian Sillaber; Wolfgang R Sperr; Hans-Jörg Bühring; Peter Valent
Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
Journal of leukocyte biology 2005;77(6):984-92.
2005: Birgit Kainz; Christa Fonatsch; Ilse Schwarzinger; Wolfgang R Sperr; Ulrich Jäger; Alexander Gaiger
Limited value of FLT3 mRNA expression in the bone marrow for prognosis and monitoring of patients with acute myeloid leukemia.
Haematologica 2005;90(5):695-6.
2005: Stefan Florian; Maria-Theresa Krauth; Ingrid Simonitsch-Klupp; Wolfgang R Sperr; Robert Fritsche-Polanz; Karoline Sonneck; Manuela Födinger; Hermine Agis; Alexandra Böhm; Friedrich Wimazal; Hans-Peter Horny; Peter Valent
Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
International archives of allergy and immunology 2005;136(3):273-80.
2005: Tanja Ball; William Edstrom; Ludwig Mauch; Jacky Schmitt; Bernd Leistler; Helmut Fiebig; Wolfgang R Sperr; Alexander W Hauswirth; Peter Valent; Dietrich Kraft; Steven C Almo; Rudolf Valenta
Gain of structure and IgE epitopes by eukaryotic expression of the major Timothy grass pollen allergen, Phl p 1.
The FEBS journal 2005;272(1):217-27.
2005: Peter Valent; Cem Akin; Wolfgang R Sperr; Matthias Mayerhofer; Manuela Födinger; Robert Fritsche-Polanz; Karl Sotlar; Luis Escribano; Michel AROCK; Hans-Peter Horny; Dean D Metcalfe
Mastocytosis: pathology, genetics, and current options for therapy.
Leukemia & lymphoma 2005;46(1):35-48.
2005: Sophie Ziegler; Wolfgang R Sperr; Paul Knoebl; Stephan Lehr; Ansgar Weltermann; Ulrich Jäger; Peter Valent; Klaus Lechner
Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.
Thrombosis research 2005;115(1-2):59-64.
2004: Peter Valent; Michel AROCK; Stephan C Bischoff; Hans-Jörg Bühring; Knut Brockow; Luis Escribano; Manuela Födinger; Jürgen Grabbe; Karin Hartmann; Beate M Henz; Hans-Peter Horny; Hanneke C Kluin-Nelemans; Margarida Lima; Gianni Marone; Alberto Orfao; Reza Parwaresch; Christian Sillaber; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Jasper J van Doormaal; Klaus Wolff; Torsten Zuberbier
The European Competence Network on Mastocytosis (ECNM).
Wiener klinische Wochenschrift 2004;116(19-20):647-51.
2004: Brigitte Meyer; Friederike Traunmüller; Ahmad Hamwi; Ursula Hollenstein; Gottfried J Locker; Wolfgang R Sperr; Thomas Staudinger; Renate Thalhammer-Scherrer; Heinz Burgmann; Florian Thalhammer
Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage.
International journal of clinical pharmacology and therapeutics 2004;42(10):556-60.
2004: Margarete Focke; Birgit Linhart; Arnulf Hartl; Ursula Wiedermann; Wolfgang R Sperr; Peter Valent; Josef Thalhamer; Dietrich Kraft; Rudolf Valenta
Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2004;34(10):1525-33.
2004: Wolfgang Füreder; Martin Filipits; Wolfgang R Sperr; Birgit Kainz; Ulrich Jäger; Christa Fonatsch; Ilse Schwarzinger; Oskar A Haas; Robert Pirker; Klaus Lechner
Highly refractory acute myeloid leukemia.
Wiener klinische Wochenschrift 2004;116(15-16):561-4.
2004: Peter Valent; Minoo Ghannadan; Cem Akin; Maria-Theresa Krauth; Edgar Selzer; Matthias Mayerhofer; Wolfgang R Sperr; Michel AROCK; Puchit Samorapoompichit; Hans-Peter Horny; Dean D Metcalfe
On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.
European journal of clinical investigation 2004;34 Suppl 2():41-52.
2004: Wolfgang R Sperr; Alexander W Hauswirth; Stefan Florian; Leopold Ohler; Klaus Geissler; Peter Valent
Human leukaemic stem cells: a novel target of therapy.
European journal of clinical investigation 2004;34 Suppl 2():31-40.
2004: Hermine Agis; Christine Mannhalter; Wolfgang R Sperr; Felix Keil; Peter Kalhs; Hendrati Pirc-Danoewinata; Maria-Theresa Krauth; Oskar A Haas; Klaus Geissler; Klaus Lechner; Peter Valent
Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantation.
Leukemia & lymphoma 2004;45(7):1453-8.
2004: Werner Rabitsch; Wolfgang R Sperr; Klaus Lechner; Andreas Chott; Erika Prinz; Peter Valent; Peter Kalhs
Bone marrow microvessel density and its prognostic significance in AML.
Leukemia & lymphoma 2004;45(7):1369-73.
2004: Peter Valent; Wolfgang R Sperr; Lawrence B Schwartz; Hans-Peter Horny
Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
The Journal of allergy and clinical immunology 2004;114(1):3-11; quiz 12.
2004: Wolfgang R Sperr; Maria Piribauer; Friedrich Wimazal; Christa Fonatsch; Renate Thalhammer-Scherrer; Ilse Schwarzinger; Klaus Geissler; Paul Knoebl; Ulrich Jäger; Klaus Lechner; Peter Valent
A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5).
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):3965-71.
2004: Peter Valent; Christa Fonatsch; Reinhard Stindl; Ilse Schwarzinger; Oskar A Haas; Wolfgang R Sperr; Klaus Geissler; Klaus Lechner
Normal bone marrow function over 6 years in a patient with dysplastic hematopoiesis and a complex karyotype.
Leukemia research 2004;28(6):651-5.
2004: Ines Swoboda; Monika Grote; Petra Verdino; Walter Keller; Mohan B Singh; Nicole de Weerd; Wolfgang R Sperr; Peter Valent; Nadja Balic; Rudolf Reichelt; Roland Suck; Helmut Fiebig; Rudolf Valenta; Susanne Spitzauer
Molecular characterization of polygalacturonases as grass pollen-specific marker allergens: expulsion from pollen via submicronic respirable particles.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(10):6490-500.
2004: Margit Mitterbauer; Gerlinde Mitterbauer-Hohendanner; Wolfgang R Sperr; Peter Kalhs; Hildegard T Greinix; Christa Fonatsch; Oskar A Haas; Ulrich Jäger; Christine Mannhalter; Klaus Lechner
Molecular disease eradication is a prerequisite for long-term remission in patients with t(8;21) positive acute myeloid leukemia: a single center study.
Leukemia & lymphoma 2004;45(5):971-7.
2004: Matthias Mayerhofer; Stefan Florian; Maria-Theresa Krauth; Karl J Aichberger; Martin Bilban; Rodrig Marculescu; Dieter Printz; Gerhard Fritsch; Oswald Wagner; Edgar Selzer; Wolfgang R Sperr; Peter Valent; Christian Sillaber
Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia.
Cancer research 2004;64(9):3148-54.
2004: Kerstin Westritschnig; Margarete Focke; Petra Verdino; Walter Goessler; Walter Keller; Anna Twardosz; Fatima Ferreira; Friedrich Horak; Ursula Wiedermann; Arnulf Hartl; Josef Thalhamer; Wolfgang R Sperr; Peter Valent; Rudolf Valenta
Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(9):5684-92.
2004: Friedrich Wimazal; Josef D Schwarzmeier; Karl Sotlar; Ingrid Simonitsch; Wolfgang R Sperr; Robert Fritsche-Polanz; Manuela Födinger; Jörg Schubert; Hans-Peter Horny; Peter Valent
Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V.
Leukemia & lymphoma 2004;45(4):723-9.
2004: Maria-Theresa Krauth; Ingrid Simonitsch; Karl J Aichberger; Matthias Mayerhofer; Wolfgang R Sperr; Christian Sillaber; Bruno Schneeweiss; Georg Mann; Helmut Gadner; Peter Valent
Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease.
American journal of clinical pathology 2004;121(4):473-81.
2004: Peter Valent; Alexander W Hauswirth; Susanne Natter; Wolfgang R Sperr; Hans-Jörg Bühring; Rudolf Valenta
Assays for measuring in vitro basophil activation induced by recombinant allergens.
Methods (San Diego, Calif.) 2004;32(3):265-70.
2004: Alexander W Hauswirth; Ingrid Simonitsch-Klupp; Martin Uffmann; Elisabeth Koller; Wolfgang R Sperr; Klaus Lechner; Peter Valent
Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.
Leukemia research 2004;28(3):249-57.
2004: Ansgar Weltermann; Christa Fonatsch; Oskar A Haas; H T Greinix; P Kahls; Gerlinde Mitterbauer; Ulrich Jäger; Birgit Kainz; Klaus Geissler; Peter Valent; Wolfgang R Sperr; Paul Knoebl; Ilse Schwarzinger; Andreas Gleiss; Klaus Lechner
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse.
Leukemia 2004;18(2):293-302.
2003: Peter Valent; Cem Akin; Wolfgang R Sperr; Hans-Peter Horny; Dean D Metcalfe
Mast cell proliferative disorders: current view on variants recognized by the World Health Organization.
Hematology/oncology clinics of North America 2003;17(5):1227-41.
2003: Nadine Mothes; M Heinzkill; KJ Drachenberg; Wolfgang R Sperr; Maria-Theresa Krauth; Yasamin Majlesi; Hans Semper; Peter Valent; Verena Niederberger; Dietrich Kraft; Rudolf Valenta
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2003;33(9):1198-208.
2003: Peter Valent; Cem Akin; Wolfgang R Sperr; Hans-Peter Horny; Michel AROCK; Klaus Lechner; John M Bennett; Dean D Metcalfe
Diagnosis and treatment of systemic mastocytosis: state of the art.
British journal of haematology 2003;122(5):695-717.
2003: Peter Valent; Friedrich Wimazal; Ilse Schwarzinger; Wolfgang R Sperr; Klaus Geissler
Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).
Wiener klinische Wochenschrift 2003;115(13-14):515-36.
2003: Wolfgang R Sperr; Alexander W Hauswirth; Friedrich Wimazal; Paul Knoebl; Klaus Geissler; Peter Valent
Treatment concepts for elderly patients with acute myeloid leukemia.
Wiener klinische Wochenschrift 2003;115(13-14):505-14.
2003: Christian Sillaber; Matthias Mayerhofer; Hermine Agis; Verena Sagaster; Christine Mannhalter; Wolfgang R Sperr; Klaus Geissler; Peter Valent
Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.
Wiener klinische Wochenschrift 2003;115(13-14):485-504.
2003: John-Hendrik Jordan; Eva Jäger; Wolfgang R Sperr; Ilse Schwarzinger; Manuela Födinger; Robert Fritsche-Polanz; Leopold Ohler; Klaus Geissler; Peter Valent
Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders.
European journal of clinical investigation 2003;33(7):611-8.
2003: Peter Valent; Cem Akin; Wolfgang R Sperr; Luis Escribano; Michel AROCK; Hans-Peter Horny; John M Bennett; Dean D Metcalfe
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria.
Leukemia research 2003;27(7):635-41.
2003: Sylvia Laffer; Said Hamdi; Christian Lupinek; Wolfgang R Sperr; Peter Valent; Petra Verdino; Walter Keller; Monika Grote; Karin Hoffmann-Sommergruber; Otto Scheiner; Dietrich Kraft; Marc Rideau; Rudolf Valenta
Molecular characterization of recombinant T1, a non-allergenic periwinkle (Catharanthus roseus) protein, with sequence similarity to the Bet v 1 plant allergen family.
The Biochemical journal 2003;373(Pt 1):261-9.
2003: Minoo Ghannadan; Friedrich Wimazal; Ingrid Simonitsch; Wolfgang R Sperr; Matthias Mayerhofer; Christian Sillaber; Alexander W Hauswirth; Helmut Gadner; Andreas Chott; Hans-Peter Horny; Klaus Lechner; Peter Valent
Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
American journal of clinical pathology 2003;119(5):663-71.
2003: Andrea Berer; Eva Jäger; Verena Sagaster; Berthold Streubel; Friedrich Wimazal; Wolfgang R Sperr; A Welterman; Ilse Schwarzinger; Florian Frommlet; Oskar A Haas; Peter Valent; Klaus Lechner; Klaus Geissler; Leopold Ohler
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
Annals of hematology 2003;82(5):271-7.
2003: Puchit Samorapoompichit; Marianne Steiner; Trevor Lucas; Franz J Wachtler; Andreas Schedled; Wolfgang R Sperr; Peter Valent
Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs.
Leukemia & lymphoma 2003;44(3):509-15.
2003: Yasamin Majlesi; Puchit Samorapoompichit; Alexander W Hauswirth; Gerit-Holger Schernthaner; Minoo Ghannadan; Mehrdad Baghestanian; Abdolreza Rezaie-Majd; Rudolf Valenta; Wolfgang R Sperr; Hans-Jörg Bühring; Peter Valent
Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3.
Journal of leukocyte biology 2003;73(1):107-17.
2002: Wolfgang R Sperr; Alexander W Hauswirth; Peter Valent
Tryptase a novel biochemical marker of acute myeloid leukemia.
Leukemia & lymphoma 2002;43(12):2257-61.
2002: Wolfgang Füreder; Gerlinde Mitterbauer; Renate Thalhammer; Klaus Geissler; Simon Panzer; Michael Krebs; Ingrid Simonitsch-Klupp; Wolfgang R Sperr; Klaus Lechner; Paul A Kyrle
Clonal T cell-mediated cyclic thrombocytopenia.
British journal of haematology 2002;119(4):1059-61.
2002: Matthias Mayerhofer; Peter Valent; Wolfgang R Sperr; James D Griffin; Christian Sillaber
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.
Blood 2002;100(10):3767-75.
2002: Sabine Stumvoll; Jonas Lidholm; Roland Thunberg; Asa Marknell DeWitt; Petra Eibensteiner; Ines Swoboda; Agnes Bugajska-Schretter; Susanne Spitzauer; Luca Vangelista; Lili Kazemi-Shirazi; Wolfgang R Sperr; Peter Valent; Dietrich Kraft; Rudolf Valenta
Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential.
Biological chemistry 2002;383(9):1383-96.
2002: A Marknell DeWitt; Verena Niederberger; P Lehtonen; Susanne Spitzauer; Wolfgang R Sperr; Peter Valent; Rudolf Valenta; Jonas Lidholm
Molecular and immunological characterization of a novel timothy grass (Phleum pratense) pollen allergen, Phl p 11.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(9):1329-40.
2002: Sabine Flicker; Peter Steinberger; Lars Norderhaug; Wolfgang R Sperr; Yasamin Majlesi; Peter Valent; Dietrich Kraft; Rudolf Valenta
Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody.
European journal of immunology 2002;32(8):2156-62.
2002: Johann Wojta; Christoph Kaun; Gerlinde Zorn; Minoo Ghannadan; Alexander W Hauswirth; Wolfgang R Sperr; Gerhard Fritsch; Dieter Printz; Bernd R Binder; Georg Schatzl; Jörg Zwirner; Gerald Maurer; Kurt Huber; Peter Valent
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils.
Blood 2002;100(2):517-23.
2002: Michael Krebs; B Meyer; P Quehenberger; Peter L Turecek; M Hejna; Wolfgang R Sperr; Klaus Lechner; Ingrid Pabinger
Massive postoperative intramuscular bleeding in acquired von Willebrand's disease.
Annals of hematology 2002;81(7):394-6.
2002: Alexander W Hauswirth; Susanne Natter; Minoo Ghannadan; Yasamin Majlesi; Gerit-Holger Schernthaner; Wolfgang R Sperr; Hans-Jörg Bühring; Rudolf Valenta; Peter Valent
Recombinant allergens promote expression of CD203c on basophils in sensitized individuals.
The Journal of allergy and clinical immunology 2002;110(1):102-9.
2002: Wolfgang R Sperr; John-Hendrik Jordan; Michael Fiegl; Luis Escribano; Carmen Bellas; Stephan Dirnhofer; Hans Semper; Ingrid Simonitsch-Klupp; Hans-Peter Horny; Peter Valent
Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
International archives of allergy and immunology 2002;128(2):136-41.
2002: Alexander W Hauswirth; Wolfgang R Sperr; Minoo Ghannadan; Gerit-Holger Schernthaner; John-Hendrik Jordan; Robert Fritsche-Polanz; Ingrid Simonitsch-Klupp; Manuela Födinger; Klaus Lechner; Peter Valent
A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy.
Leukemia research 2002;26(6):601-6.
2002: Wolfgang R Sperr; B Stehberger; Friedrich Wimazal; Mehrdad Baghestanian; Lawrence B Schwartz; M Kundi; Hans Semper; John-Hendrik Jordan; Andreas Chott; J Drach; Ulrich Jäger; Klaus Geissler; A Greschniok; Hans-Peter Horny; Klaus Lechner; Peter Valent
Serum tryptase measurements in patients with myelodysplastic syndromes.
Leukemia & lymphoma 2002;43(5):1097-105.
2002: Peter Valent; Minoo Ghannadan; Alexander W Hauswirth; Gerit-Holger Schernthaner; Wolfgang R Sperr; Michel AROCK
Signal transduction-associated and cell activation-linked antigens expressed in human mast cells.
International journal of hematology 2002;75(4):357-62.
2002: Peter Valent; Mehrdad Baghestanian; Hans C Bankl; Christian Sillaber; Wolfgang R Sperr; Johann Wojta; Bernd R Binder; Klaus Lechner
New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells.
Thrombosis and haemostasis 2002;87(5):786-90.
2002: Friedrich Wimazal; John-Hendrik Jordan; Wolfgang R Sperr; Andreas Chott; Sana Dabbass; Klaus Lechner; Hans-Peter Horny; Peter Valent
Increased angiogenesis in the bone marrow of patients with systemic mastocytosis.
The American journal of pathology 2002;160(5):1639-45.
2002: Ines Swoboda; Agnes Bugajska-Schretter; Petra Verdino; Walter Keller; Wolfgang R Sperr; Peter Valent; Rudolf Valenta; Susanne Spitzauer
Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(9):4576-84.
2002: Minoo Ghannadan; Alexander W Hauswirth; Gerit-Holger Schernthaner; Martin R Müller; Walter Klepetko; Georg Schatzl; Wolfgang R Sperr; Hans-Jörg Bühring; Peter Valent
Detection of novel CD antigens on the surface of human mast cells and basophils.
International archives of allergy and immunology 2002;127(4):299-307.
2002: John-Hendrik Jordan; Gerit-Holger Schernthaner; Robert Fritsche-Polanz; Wolfgang R Sperr; Manuela Födinger; Andreas Chott; Klaus Geissler; Klaus Lechner; Hans-Peter Horny; Peter Valent
Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria.
Leukemia & lymphoma 2002;43(3):575-82.
2002: Wolfgang R Sperr; Hans-Peter Horny; Peter Valent
Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.
International archives of allergy and immunology 2002;127(2):140-2.
2002: Peter Valent; Cem Akin; Wolfgang R Sperr; Hans-Peter Horny; Dean D Metcalfe
Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression.
International archives of allergy and immunology 2002;127(2):137-9.
2002: Wolfgang Füreder; U Firbas; Janet L Nichol; J Pistillo; S Winkler; H Hiesberger; Wolfgang R Sperr; Josef Smolen; Georg Schett
Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus.
Lupus 2002;11(4):221-6.
2002: Peter Valent; Puchit Samorapoompichit; Wolfgang R Sperr; Hans-Peter Horny; Klaus Lechner
Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(2):90-4.
2002: Ines Swoboda; Nicole de Weerd; Prem L Bhalla; Verena Niederberger; Wolfgang R Sperr; Peter Valent; Helga Kahlert; Helmut Fiebig; Petra Verdino; Walter Keller; Christof Ebner; Susanne Spitzauer; Rudolf Valenta; Mohan B Singh
Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy.
European journal of immunology 2002;32(1):270-80.
2001: M Binder; Vera Mahler; Brigitte Hayek; Wolfgang R Sperr; M Schöller; S Prozell; Gerhard Wiedermann; Peter Valent; Rudolf Valenta; Michael Duchêne
Molecular and immunological characterization of arginine kinase from the Indianmeal moth, Plodia interpunctella, a novel cross-reactive invertebrate pan-allergen.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(9):5470-7.
2001: Puchit Samorapoompichit; Hans P Kiener; Gerit-Holger Schernthaner; John-Hendrik Jordan; Hermine Agis; Friedrich Wimazal; Mehrdad Baghestanian; Abdolreza Rezaie-Majd; Wolfgang R Sperr; Klaus Lechner; Peter Valent
Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms.
Blood 2001;98(8):2580-3.
2001: Wolfgang Füreder; Gerit-Holger Schernthaner; Minoo Ghannadan; Alexander W Hauswirth; Wolfgang R Sperr; Hans Semper; Yasamin Majlesi; Jörg Zwirner; Otto Götze; Hans-Jörg Bühring; Klaus Lechner; Peter Valent
Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes.
European journal of clinical investigation 2001;31(10):894-901.
2001: Wolfgang R Sperr; John-Hendrik Jordan; Mehrdad Baghestanian; Hans P Kiener; Puchit Samorapoompichit; Hans Semper; Alexander W Hauswirth; Gerit-Holger Schernthaner; Andreas Chott; Susanne Natter; Dietrich Kraft; Rudolf Valenta; Lawrence B Schwartz; Klaus Geissler; Klaus Lechner; Peter Valent
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.
Blood 2001;98(7):2200-9.
2001: Sylvia Laffer; E Hogbom; K H Roux; Wolfgang R Sperr; Peter Valent; Hans C Bankl; Luca Vangelista; F Kricek; Dietrich Kraft; Hans Grönlund; Rudolf Valenta
A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgE.
The Journal of allergy and clinical immunology 2001;108(3):409-16.
2001: Margarete Focke; Vera Mahler; Tanja Ball; Wolfgang R Sperr; Yasamin Majlesi; Peter Valent; Dietrich Kraft; Rudolf Valenta
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(11):2042-4.
2001: Susanne Vrtala; Kora Hirtenlehner; Markus Susani; Mübeccel Akdis; Fatimah Kussebi; Cezmi A. Akdis; Kurt Blaser; Peter Hufnagl; Bernd R Binder; A Politou; A Pastore; Luca Vangelista; Wolfgang R Sperr; Hans Semper; Peter Valent; Christof Ebner; Dietrich Kraft; Rudolf Valenta
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(11):2045-7.
2001: John-Hendrik Jordan; Robert Fritsche-Polanz; Wolfgang R Sperr; Gerlinde Mitterbauer; Manuela Födinger; Gerit-Holger Schernthaner; H Christian Bankl; W Gebhart; Andreas Chott; Klaus Lechner; Peter Valent
A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
Leukemia research 2001;25(7):627-34.
2001: Peter Valent; Hans-Peter Horny; Luis Escribano; B Jack Longley; C Y Li; Lawrence B Schwartz; G Marone; R Nuñez; Cem Akin; Karl Sotlar; Wolfgang R Sperr; Klaus Wolff; Richard D Brunning; Reza Parwaresch; K F Austen; K Lennert; Dean D Metcalfe; James W Vardiman; John M Bennett
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Leukemia research 2001;25(7):603-25.
2001: Peter Valent; Wolfgang R Sperr; Puchit Samorapoompichit; Klaus Geissler; Klaus Lechner; Hans-Peter Horny; John M Bennett
Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Leukemia research 2001;25(7):595-602.
2001: Luis Escribano; Beatriz Díaz-Agustín; Carmen Bellas; R Navalón; R Nuñez; Wolfgang R Sperr; Gerit-Holger Schernthaner; Peter Valent; Alberto Orfao
Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
Leukemia research 2001;25(7):563-70.
2001: Wolfgang R Sperr; Luis Escribano; John-Hendrik Jordan; Gerit-Holger Schernthaner; M Kundi; Hans-Peter Horny; Peter Valent
Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.
Leukemia research 2001;25(7):529-36.
2001: Wolfgang R Sperr; Friedrich Wimazal; M Kundi; Christa Fonatsch; Renate Thalhammer-Scherrer; Gerit-Holger Schernthaner; Ilse Schwarzinger; Oskar A Haas; Klaus Geissler; Klaus Lechner; Peter Valent
Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems.
Annals of hematology 2001;80(5):272-7.
2001: John-Hendrik Jordan; S Walchshofer; Wolfgang Jurecka; Isabella Mosberger; Wolfgang R Sperr; Klaus Wolff; Andreas Chott; Hans-Jörg Bühring; Klaus Lechner; Hans-Peter Horny; Peter Valent
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Human pathology 2001;32(5):545-52.
2001: Robert Fritsche-Polanz; John-Hendrik Jordan; Alexandra Feix; Wolfgang R Sperr; Gere Sunder-Plassmann; Peter Valent; Manuela Födinger
Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.
British journal of haematology 2001;113(2):357-64.
2001: Friedrich Wimazal; Wolfgang R Sperr; M Kundi; P Meidlinger; Christa Fonatsch; John-Hendrik Jordan; Renate Thalhammer-Scherrer; Ilse Schwarzinger; Klaus Geissler; Klaus Lechner; Peter Valent
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes.
Leukemia research 2001;25(4):287-94.
2001: Peter Valent; Gerit-Holger Schernthaner; Wolfgang R Sperr; Gerhard Fritsch; Hermine Agis; Martin Willheim; Hans-Jörg Bühring; A Orfao; Luis Escribano
Variable expression of activation-linked surface antigens on human mast cells in health and disease.
Immunological reviews 2001;179():74-81.
2000: Gerit-Holger Schernthaner; E Spanblöchl; Wolfgang R Sperr; Christian Sillaber; Hans Semper; Wolfgang Jurecka; W Hagen; Klaus Wolff; Andreas Chott; Klaus Lechner; Peter Valent
Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis.
Annals of hematology 2000;79(12):660-6.
2000: Sabine Flicker; Susanne Vrtala; Peter Steinberger; Luca Vangelista; A Bufe; A Petersen; Minoo Ghannadan; Wolfgang R Sperr; Peter Valent; L Norderhaug; Barbara Bohle; Hannes Stockinger; C Suphioglu; E K Ong; Dietrich Kraft; Rudolf Valenta
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(7):3849-59.
2000: Wolfgang R Sperr; Susanne Natter; Mehrdad Baghestanian; Josef Smolen; Klaus Wolff; Bernd R Binder; Martin R Müller; Klaus Lechner; Rudolf Valenta; Peter Valent
Autoantibody reactivity in a case of Schnitzler's syndrome: evidence for a Th1-like response and detection of IgG2 anti-FcepsilonRIalpha antibodies.
International archives of allergy and immunology 2000;122(4):279-86.
2000: Wolfgang R Sperr; Hans-Peter Horny; Klaus Lechner; Peter Valent
Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.
Leukemia & lymphoma 2000;37(5-6):473-86.
2000: Agnes Bugajska-Schretter; Monika Grote; Luca Vangelista; Peter Valent; Wolfgang R Sperr; Helmut Rumpold; A Pastore; Rudolf Reichelt; Rudolf Valenta; Susanne Spitzauer
Purification, biochemical, and immunological characterisation of a major food allergen: different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbumin.
Gut 2000;46(5):661-9.
1999: Susanne Vrtala; S Fischer; Monika Grote; Luca Vangelista; A Pastore; Wolfgang R Sperr; Peter Valent; Rudolf Reichelt; Dietrich Kraft; Rudolf Valenta
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5489-96.
1999: Friedrich Wimazal; Minoo Ghannadan; Martin R Müller; Adelheid End; Martin Willheim; P Meidlinger; Gerit-Holger Schernthaner; John-Hendrik Jordan; W Hagen; Hermine Agis; Wolfgang R Sperr; K Czerwenka; Klaus Lechner; Peter Valent
Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniques.
Tissue antigens 1999;54(5):499-507.
1999: Peter Valent; Luis Escribano; Reza Parwaresch; V Schemmel; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Hans-Peter Horny
Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.
International archives of allergy and immunology 1999;120(1):1-7.
1999: Tanja Ball; T Fuchs; Wolfgang R Sperr; Peter Valent; Luca Vangelista; Dietrich Kraft; Rudolf Valenta
B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(11):1277-90.
1999: Tanja Ball; Wolfgang R Sperr; Peter Valent; Jonas Lidholm; Susanne Spitzauer; Christof Ebner; Dietrich Kraft; Rudolf Valenta
Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
European journal of immunology 1999;29(6):2026-36.
1999: Luca Vangelista; Sylvia Laffer; R Turek; Hans Grönlund; Wolfgang R Sperr; Peter Valent; A Pastore; Rudolf Valenta
The immunoglobulin-like modules Cepsilon3 and alpha2 are the minimal units necessary for human IgE-FcepsilonRI interaction.
The Journal of clinical investigation 1999;103(11):1571-8.
1999: Friedrich Wimazal; Wolfgang R Sperr; Hans-Peter Horny; VA Carroll; Bernd R Binder; Christa Fonatsch; S Walchshofer; Manuela Födinger; Ilse Schwarzinger; Puchit Samorapoompichit; Andreas Chott; A M Dvorak; Klaus Lechner; Peter Valent
Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells.
American journal of hematology 1999;61(1):66-77.
1999: Verena Niederberger; Brigitte Hayek; Susanne Vrtala; Sylvia Laffer; Anna Twardosz; Luca Vangelista; Wolfgang R Sperr; Peter Valent; Helmut Rumpold; Dietrich Kraft; Klaus Ehrenberger; Rudolf Valenta; Susanne Spitzauer
Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(8):843-56.
1999: Susanne Vrtala; Kora Hirtenlehner; Markus Susani; Peter Hufnagl; Bernd R Binder; Luca Vangelista; A Pastore; Wolfgang R Sperr; Peter Valent; Christof Ebner; Dietrich Kraft; Rudolf Valenta
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy.
International archives of allergy and immunology 1999;118(2-4):218-9.
1998: Brigitte Hayek; Luca Vangelista; A Pastore; Wolfgang R Sperr; Peter Valent; Susanne Vrtala; Verena Niederberger; Anna Twardosz; Dietrich Kraft; Rudolf Valenta
Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):7031-9.
1998: Wolfgang R Sperr; S Walchshofer; Hans-Peter Horny; Manuela Födinger; Ingrid Simonitsch; Robert Fritsche-Polanz; Ilse Schwarzinger; Erwin Tschachler; Christian Sillaber; W Hagen; Klaus Geissler; Andreas Chott; Klaus Lechner; Peter Valent
Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.
British journal of haematology 1998;103(3):740-9.
1998: Andreas Schedle; Puchit Samorapoompichit; Minoo Ghannadan; Alexander Franz; Wolfgang R Sperr; Wolfgang Sperr; Peter Valent
Effects of dental amalgam and its components of histamine release from human basophils and tissue mast cells.
Wiener klinische Wochenschrift 1998;110(13-14):467-72.
1998: Susanne Vrtala; Tanja Ball; Susanne Spitzauer; B Pandjaitan; C Suphioglu; B Knox; Wolfgang R Sperr; Peter Valent; Dietrich Kraft; Rudolf Valenta
Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):6137-44.
1998: Wolfgang R Sperr; Kurt Huber; M Roden; Michael Janisiw; T Lang; Senta Graf; Gerald Maurer; Wolfgang R Mayr; Simon Panzer
Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans.
Thrombosis research 1998;90(3):117-23.
1998: Andreas Schedle; Puchit Samorapoompichit; Wolfgang Füreder; Xiaohui Rausch-Fan; Alexander Franz; Wolfgang R Sperr; Wolfgang Sperr; R Slavicek; S Simak; Walter Klepetko; Adolf Ellinger; Minoo Ghannadan; Mehrdad Baghestanian; Peter Valent
Metal ion-induced toxic histamine release from human basophils and mast cells.
Journal of biomedical materials research 1998;39(4):560-7.
1998: Friedrich Wimazal; S Walchshofer; Mehrdad Baghestanian; Andreas Chott; Wolfgang R Sperr; C Kopp; Christian Sillaber; Hans Semper; Hans-Peter Horny; U Tröndle; Manuela Födinger; Ilse Schwarzinger; Klaus Lechner; Peter Valent
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
Wiener klinische Wochenschrift 1998;110(3):79-88.
1998: R Hirschwehr; C Heppner; Susanne Spitzauer; Wolfgang R Sperr; Peter Valent; U Berger; Friedrich Horak; S Jäger; Dietrich Kraft; Rudolf Valenta
Identification of common allergenic structures in mugwort and ragweed pollen.
The Journal of allergy and clinical immunology 1998;101(2 Pt 1):196-206.
1997: Wolfgang R Sperr; Hermine Agis; Hans Semper; Rudolf Valenta; Markus Susani; M Sperr; Martin Willheim; Otto Scheiner; E Liehl; Klaus Lechner; Peter Valent
Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506.
International archives of allergy and immunology 1997;114(1):68-73.
1997: Susanne Vrtala; Kora Hirtenlehner; Luca Vangelista; A Pastore; H G Eichler; Wolfgang R Sperr; Peter Valent; Christof Ebner; Dietrich Kraft; Rudolf Valenta
Division of the major birch pollen allergen, Bet v 1, into two non-anaphylactic fragments.
International archives of allergy and immunology 1997;113(1-3):246-8.
1997: Susanne Vrtala; Kora Hirtenlehner; Luca Vangelista; A Pastore; H G Eichler; Wolfgang R Sperr; Peter Valent; Christof Ebner; Dietrich Kraft; Rudolf Valenta
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.
The Journal of clinical investigation 1997;99(7):1673-81.